Study and comparison of the course of frozen shoulder after intra-articular steroid injection versus patients treated with TECAR therapy in Shahrekord city : A randomized clinical trial
Determination and comparison of shoulder joint range of motion (internal rotation, external rotation, anterior flexion) in the study groups across the assessed time points
Assisting in the selection of the optimal treatment method for patients with frozen shoulder in physiotherapy and pain management clinics
Providing scientific evidence to improve rehabilitation and treatment protocols for patients with frozen shoulder in Iran
Reducing patient treatment costs by selecting more effective treatment methods and shortening the period of disability
Design
A two-phase, single-blind, parallel-group, controlled clinical trial involving 44 patients, with randomization performed using randomization software.
Settings and conduct
This study was designed as a single-blind, randomized clinical trial in Shahrekord to investigate the effect of intraarticular steroid injection compared to TECAR therapy on the recovery of patients with frozen shoulder.To minimize observer bias, each patient will be assigned a unique code by the treating physician, and patients will be identified by these codes.
Participants/Inclusion and exclusion criteria
Diagnosis of frozen shoulder
Age 40–60 years
Willingness and informed consent to participate in the study
Absence of radiculopathy
Absence of osteoarthritis
Absence of severe diabetes
No prior treatment in the shoulder area
Intervention groups
The first group will undergo treatment with an intraarticular steroid injection. Triamcinolone acetonide (40 mg) will be used in this study.
The second group will undergo TECAR therapy. Treatment will consist of five sessions, each lasting approximately 15 minutes, administered over a two-week period.
Main outcome variables
Assisting in the selection of the optimal treatment method for patients with frozen shoulder, and reducing treatment costs by choosing a more effective approach and shortening the period of disability.
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20260906070929N2
Registration date:2026-10-14, 1405/07/22
Registration timing:registered_while_recruiting
Last update:2026-10-14, 1405/07/22
Update count:0
Registration date
2026-10-14, 1405/07/22
Registrant information
Name
Ashkan Salehi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 38 3226 4839
Email address
salehi.ashkan@skums.ac.ir
Recruitment status
recruiting
Funding source
Expected recruitment start date
2026-10-13, 1405/07/21
Expected recruitment end date
2027-04-20, 1406/01/31
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Study and comparison of the course of frozen shoulder after intra-articular steroid injection versus patients treated with TECAR therapy in Shahrekord city : A randomized clinical trial
Public title
Comparison of the Effects of Steroid Injection and TECAR Therapy on Frozen Shoulder
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Developing frozen shoulder
Ages 40 to 60
Willingness and informed consent to participate in the research
Absence of radiculopathy
Absence of osteoarthritis
Absence of severe diabetes
No prior treatment in the shoulder area
Exclusion criteria:
prior treatment in the shoulder area
Developing severe diabetes
Developing osteoarthritis
Developing radiculopathy
Age
From 40 years old to 60 years old
Gender
Both
Phase
2
Groups that have been masked
Investigator
Outcome assessor
Sample size
Target sample size:
44
Randomization (investigator's opinion)
Randomized
Randomization description
Simple randomization
Randomization unit: Individual
Measurement tool: Random selection software
Eligible participants who meet the inclusion criteria will be informed about the study, and written informed consent will be obtained before enrollment. Participants will then be randomly assigned to one of two intervention groups: the intra-articular corticosteroid injection group or the TECAR therapy group. Random allocation will be performed using Random Allocation Software.
The study will include 44 participants, with a target of 22 participants in each group. To maintain balanced group sizes throughout recruitment, block randomization may be used to generate the allocation sequence. The allocation sequence will be prepared by an independent individual who is not involved in participant recruitment, treatment administration, or outcome assessment. Allocation concealment will be maintained until each participant has been enrolled and is ready to receive the assigned intervention, using sequentially numbered, opaque, sealed envelopes.
All interventions will be performed by a specialist in Physical Medicine and Rehabilitation. Due to the nature of the interventions, blinding of participants and the treating specialist will not be feasible. However, outcome assessments will be conducted by an orthopedist and a medical student who will remain unaware of the participants’ group assignments. Participants’ demographic and clinical data, treatment allocation, and outcome measurements will be recorded using study identification codes to maintain confidentiality.
Blinding (investigator's opinion)
Single blinded
Blinding description
This study is designed as a single-blind trial. Following the random assignment of patients to two treatment groups, all interventions—including intra-articular steroid injections and TECAR therapy—will be performed by a specialist in physical medicine and rehabilitation. Given the distinct nature of the two treatment modalities, blinding both the patient and the administering physician is not feasible; consequently, both the patients and the treating physician will be aware of the assigned treatment. To minimize assessment bias, the treating physician will assign a specific code to each patient, and patients will be identified solely by these codes. All clinical assessments at the scheduled time points will be conducted by an orthopedist and a student—who will remain unaware of the patients' identities and the specific interventions administered—based exclusively on the patient codes.
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Research Ethics Committees of School of Medicine - Shahrekord University Of Medical Sciences
Street address
Ayatollah Kashani Hospital, Parastar St., Shahrekord, Chaharmahal and Bakhtiari Province
City
Shahrekord
Province
Chahar-Mahal-va-Bakhtiari
Postal code
۸۸۱۶۷۵۸۹۱۵
Approval date
2026-09-23, 1405/07/01
Ethics committee reference number
IR.SKUMS.MED.REC.1405.160
Health conditions studied
1
Description of health condition studied
Frozen shoulder
ICD-10 code
M75.0
ICD-10 code description
Adhesive capsulitis of shoulder
Primary outcomes
1
Description
Total score of the Shoulder Pain and Disability Index questionnaire
Timepoint
Measurement of the total score on the Shoulder Pain and Disability Index (SPADI) questionnaire at baseline and at 1 and 3 months after the start of treatment.
Method of measurement
Pain and Disability Index (SPADI) questionnaire
Secondary outcomes
1
Description
Visual Analogue Scale (VAS) questionnaire score
Timepoint
At baseline, and 1 month and 3 months after the start of treatment
Method of measurement
Visual analogue scale
Intervention groups
1
Description
Intervention group: They will undergo intraarticular steroid injection. The injection will be performed under ultrasound guidance by a single practitioner (a physical medicine specialist). The medication used will be triamcinolone acetonide (40 mg/mL); a volume of 1 mL will be injected, combined with 2 mL of 1% lidocaine, in a single session. Following the injection, patients will receive instructions regarding relative rest and the performance of gentle pendulum exercises for the shoulder. No other physiotherapy or pharmacological treatment will be prescribed during the follow-up period, so that the isolated effect of the injection can be evaluated.
Category
Treatment - Drugs
2
Description
Intervention group: Patients will undergo Tecar therapy. The treatment will consist of five sessions—each lasting approximately 15 minutes—conducted over a two-week period. The therapy will be administered using a device featuring both capacitive and resistive modes: the capacitive mode will target superficial tissues such as muscles, while the resistive mode will address deeper tissues, including tendons and joint capsules. An experienced physiatrist will perform the treatment, adjusting the current intensity according to the patient's tolerance threshold to ensure a pleasant warming sensation without any burning. Patients will be positioned comfortably and correctly throughout the procedure, and no supplementary medications or injections will be used.
Category
Treatment - Other
Recruitment centers
1
Recruitment center
Name of recruitment center
Imam Ali Specialized and Subspecialized Clinic, Shahrekord
Full name of responsible person
Ashkan Salehi
Street address
Imam Ali Specialized and Subspecialized Clinic, Shariati Blvd., Shahrekord
City
shahrekord
Province
Chahar-Mahal-va-Bakhtiari
Postal code
۸۸۱۶۷۵۸۹۱۵
Phone
+98 38 3224 2090
Email
Kashani@skums.ac.ir
Web page address
https://imamaliclinic.skums.ac.ir/
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Shahre-kord University of Medical Sciences
Full name of responsible person
Masoumeh Moezi
Street address
Educational Complex of Shahrekord University of Medical Sciences, Rahmatiyeh, Shahrekord
City
shahrekord
Province
Chahar-Mahal-va-Bakhtiari
Postal code
8813433411
Phone
+98 38 3333 9940
Email
res.med@skums.ac.ir
Web page address
https://medresearch.skums.ac.ir/
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?